Newsletter
Every new paper in this field, in your inbox.
In patients undergoing minimally invasive colorectal resections within an enhanced recovery after surgery (ERAS) protocol, extended venous thromboembolism (VTE) prophylaxis significantly reduces post-discharge VTE rates, albeit with a small absolute risk reduction.
Robot-assisted total mesorectal excision (R-TME) significantly increases the likelihood of achieving primary anastomosis compared to laparoscopic TME (L-TME), with an odds ratio of 1.43.
A new standardized technique for double-stapled intracorporeal anastomosis simplifies minimally invasive right and left colectomies, making the procedure more reproducible and teachable.
Circulating tumor DNA (ctDNA) testing provides significant prognostic information post-curative treatment for colorectal cancer, impacting patient management and surveillance strategies.
Using an unsutured composite technique for loop ileostomy after laparoscopic low anterior resection significantly reduces parastomal hernia risk compared to a sutured technique.
Surgery for stage I-III colon cancer performed within 48 days of diagnosis significantly improves 5-year survival compared to later procedures.
Nonoperative management of colonic fistulas in necrotizing pancreatitis can be effective for low-risk patients, reducing complications and length of stay without affecting survival.
A new consensus from the World Society of Emergency Surgery emphasizes a selective, physiology-driven approach for managing colon and rectal trauma, moving away from routine fecal diversion.
Pretreatment nutritional and inflammatory markers do not identify patients with unresectable metastatic colorectal cancer who would benefit from primary tumor resection (PTR) over upfront chemotherapy.
Laparoscopic surgery offers noninferior progression-free survival compared to open surgery for noncurable stage IV colon cancer patients, making it a viable option.
